In Silico Analysis of Antiviral Activity and Pharmacokinetic Prediction of Brazilein Sappan Wood (Caesalpinia sappan L.) Against SARS-CoV-2 Spike Glycoproteins
Article Sidebar
Main Article Content
Abstract
Brazilein is one of the secondary sappan wood metabolites which can be used empirically as an antivirus. The SARS-CoV-2 spike (S) glycoproteins play significant roles in attaching and entering the virus into the host cell. This study aims to predict the antiviral activity and pharmacokinetic properties of brazilein of the sappan wood against the in-silico SARS-CoV-2 S glycoproteins with vitamin C as the reference compound. Molegro Virtual Docker 5.5 was used to predict antiviral activity by docking process. SARS-CoV-2 S glycoprotein with NAG ligand available in Protein Data Bank (PDB) (PDB ID: 7C01) was the receptor used. The pkCSM online tool was used to predict the pharmacokinetic properties and toxicity of brazilein. Data were analyzed on the target receptors by comparing the docking bond energies between NAG, brazilein, and vitamin C. The smaller the ligands’ bond energy to the target receptor, the more stable the bonds are. The bond energy of NAG, brazilein, and vitamin C was -59.2864 kcal/mol, -65.8911 kcal/mol, and -53.9093 kcal/mol, respectively. These results suggested that brazilein has a greater capacity as an antivirus compared to NAG and vitamin C. In silico test using the pkCSM online tool demonstrated that brazilein had strong pharmacokinetic properties and relatively low toxicity.
Downloads
Article Details
Copyright (c) 2021 Dwi Krihariyani, Edy Haryanto, Retno Sasongkowati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Setiawan HG, Kaligis AHM, Assa YA. Description of serum apolipoprotein B (APO-B) levels in lacto-ovo vegetarians. Ebiomedik. 2017;5(1):2–5.
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020; 395: 470-473.
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai, FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579: 265-69.
Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in case fatality rates (CFR) of COVID-19/SARS-CoV-2 in Italy and China. J Infect Dev Ctries. 2020; 14: 125-128.
Meethal ME, Ollakkott S, Varma GG. COVID-19 and SARS-CoV-2: molecular genetics perspectives. Indian J Nat Sci. 2020; 10: 18751-18757.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109: 1-4.
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, Sinto R, Singh G, Nainggolan L, Nelwan EJ, Chen LK, Widhani A, Wijaya E, Wicaksana B, Maksum M, Annisa F, Jasirwan COM, Yunihastuti E. Coronavirus Disease 2019: review of current literatures. J Peny Dlm Indo. 2020; 7: 45-67.
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020; 181: 281-292.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, et.al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020; 395:565-74.
Pandey P, Rane JS, Chatterjee A, Kumar A, Khan R, Prakash A, Ray S. Targeting SARS-CoV-2 spike protein of covid-19 with naturally occurring phytochemicals: an in silico study for drug development.” J Biomol Str Dyn. 2020; 1-11.
Burhan E, Susanto AD, Nasution SA, Ginanjar E, Pitoyo CW, Susilo A, Firdaus I. Protokol tatalaksana Covid-19. 2020.
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat. Med. 2020; 26: 450-452.
Shi R, Shan C, Duan X, Chen Z, Liu Z, Song J, Song T, Bi X, Han C, Wu L, Gao G, Hu Xue, et.al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020; 584: 120-24.
Aslani BA, Ghobadi S. Studies on oxidants and antiviruss with a brief glance at their relevance to the immune system. Life Sci. 2016; 146: 163-173.
Sinha SK, Prasad SK, Islam MA, Gurav SS, Patil RB, AlFaris NA, Aldayel TS, AlKeayez NM, Wabaidur SM, Shakya A. Identification of bioactive compounds from glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study. J Biomol Str Dyn 2020; 1-15.
Utari FD, Sumirat S, Djaeni M. Produksi antioksidan dari ekstrak kayu secang (Caesalpinia sappan L.) menggunakan pengering berkelembaban rendah [Antioxidant production from secang wood extract (Caesalpinia sappan L.) using a low humidity dryer]. Apl Teknol. Pangan. 2017; 6:1-4.
Kesuma D, Siswandono S, Purwanto BT, Hardjono S. Uji in silico aktivitas sitotoksik dan toksisitas senyawa turunan n-(benzoil)-n’- feniltiourea sebagai calon obat antikanker [In silico test for cytotoxic activity and toxicity of n- (benzoyl) -n'- phenyltiourea derivatives as a candidate for anticancer drugs]. JPSCR J Pharm Sci Clin Res. 2018; 3.
Hardjono S. Prediksi sifat farmakokinetik, toksisitas dan aktivitas sebagai calon obat antikanker melalui pemodelan molekul [Prediction of pharmacokinetic properties, toxicity and activity as a candidate for anticancer drugs through molecular modeling]. I Kef Indo. 2017; 14: 246–255.
Bimantara DE. The role of vitamin C in treatment COVID-19. Majority. 2020; 9:1–4.
Pires DEV, Blundell TL, Ascher DB. pkCSM : predicting small-molecule pharmacokinetic properties using graph-based signatures (Theory-How to Enterpret pkCSM Result). pKCSM, p. 5, 2015, [Online]. Available: http://biosig.unimelb.edu.au/pkcsm/theory.
Erlina B, Isbaniah F, Susanto AD, Aditama TY, Soedarsono, Sartono, Yani JSTR, et al. Pneumonia COVID-19, diagnosis & penatalaksanaan di Indonesia. Perhimpunan Dokter Paru Indonesia [Pneumonia COVID-19, Diagnosis & Management in Indonesia. Indonesian Association of Lung Doctors]. 2020.
Siswandono. Pengembangan obat baru [New drug development]. Surabaya: Airlangga University Press, 2014.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Elsevier. 1997; 1: 3-25.
Chander S, Tang CR, Al-Maqtari HM, Jamalis J, Penta A, Hadda TB, Sirat HM, Zheng YT, Snkaranarayanan M. Synthesis and study of Anti-HIV-1 RT activity of 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2h-1,5-benzodiazepin-2-one derivatives. Bioorganic Chemistry. 2017; 72: 74-79.
Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015; 58: 4066-4072.
